Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.

Eitemau Tebyg

• Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
  gan: Natalie J. Hannan, et al.
  Cyhoeddwyd: (2017-05-01)
• Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
  gan: Tu'uhevaha J Kaitu'u-Lino, et al.
  Cyhoeddwyd: (2018-01-01)
• Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
  gan: Roxanne Hastie, et al.
  Cyhoeddwyd: (2022-08-01)
• Placental galectin-3 is reduced in early-onset preeclampsia
  gan: Manju Kandel, et al.
  Cyhoeddwyd: (2022-10-01)
• Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
  gan: Stephen Tong, et al.
  Cyhoeddwyd: (2021-01-01)